Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Patients who take a close look at medical science in search of treatments are often appalled by what they discover. On the one hand, there's academic research, a self-contained and self-absorbed universe of its own where data may be internally consistent (on a good day) and robustly reproducible, yet often has little relevance to real-world clinical conditions.
The Shadow Financial Regulatory Committee works to identify and analyze developing trends and ongoing events that promise to affect the efficiency and safe operation of sectors of the financial services industry; explore the spectrum of short- and long-term implications of emerging problems and policy changes; help develop private, regulatory and legislative responses to such problems that promote efficiency and safety and further the public interest; and to assess and respond to proposed and actual public policy initiatives with respect to the impact on the public interest.
As President Obama huffs and puffs about his tax plan, which is unlikely to pass in the Democratic-majority Senate much less the Republican-controlled House, Robert Zoellick, president of the World Bank, has provided a much broader view of where the United States stands amid great changes in the world and some useful guidance on what direction public policy ought to take.
Many of those affected by US trade and domestic agricultural policies are among the poorest people on the planet.
Can the Health Impact Fund reward the makers of the best new drugs while keeping prices low? At this AEI event, experts will analyze the potential impact of this publicly funded program.
It is vitally important to find all of the root causes of substandard medicines because current policy decisions that concern drug quality often exacerbate problems related to a lack of research.





